S.M.A.R.T. and S.M.A.R.T. CONTROL Vascular Stent Systems
Cordis US Corporation · Decision date Dec 4, 2025
What did the FDA decide?
FDA records P120002/S033 as a supplement to PMA P120002, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Dec 4, 2025.
FDA approval order statement
an alternate supplier for bismuth sub carbonate (BSC) for the catheter tip
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Dec 4, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P120002/S033
- Regulatory pathway
- PMA supplement
- Applicant
- Cordis US Corporation
- Product code
- NIP
- Decision code
- OK30
- Decision date
- Dec 4, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: STENT, SUPERFICIAL FEMORAL ARTERY.
- Applicant
- Cordis US Corporation
- Product code
- NIP
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P120002. Subsequent supplements may change the device or its indications.
FDA decision timeline
P120002 · Original PMA
SMA RT CONTROL AND SMART VASCULAR STENT SYSTEMS
P120002/S032 · Related supplement
S.M.A.R.T. CONTROL Vascular Stent System
P120002/S033 received
Application receipt date recorded by FDA.
P120002/S033 · FDA decision
30-Day Notice
P120002/S034 · Related supplement
S.M.A.R.T. and S.M.A.R.T. CONTROL Vascular Stent Systems; S.M.A.R.T. RADIANZ Vascular Stent System
P120002/S036 · Related supplement
S.M.A.R.T. and S.M.A.R.T. CONTROL Vascular Stent Systems; S.M.A.R.T. RADIANZ Vascular Stent System
Timeline entries are records held by MedtechLedger for P120002. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P120002
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Cordis US Corporation | PMA approval | Nov 7, 2012 | FDA | |
S.M.A.R.T. CONTROL Vascular Stent SystemP120002/S032 | Cordis US Corporation | PMA supplement | Sep 12, 2025 | FDA |
| Cordis US Corporation | PMA supplement | Jan 8, 2026 | FDA | |
| Cordis US Corporation | PMA supplement | Oct 15, 2026 | FDA |
Explore the linked device profile
Other records with product code NIP
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Supera Peripheral Stent SystemP120020/S037 | Abbott Vascular (Idef Technologies Inc) | PMA supplement | Nov 6, 2026 | FDA |
| Medtronic Vascular, Inc. | PMA supplement | Nov 5, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
| Biotronik AG | PMA supplement | Sep 11, 2026 | FDA | |
| BOSTON SCIENTIFIC CORPORATION | PMA supplement | Aug 21, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Cordis US Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 14201 NW 60th Ave., Miami Lakes, FL, 33014
Sources and methodology
- Original FDA record: P120002/S033
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




